Blood biomarkers in the diagnosis of ischemic stroke: a systematic review

William Whiteley1, Mei-Chiun Tseng, Peter Sandercock

  • 1Division of Clinical Neurosciences, University of Edinburgh, UK. william.whiteley@ed.ac.uk

Stroke
|July 29, 2008
PubMed

Insights

Diagnosing ischemic stroke is challenging, with current imaging often insufficient. While numerous blood biomarkers show promise, study limitations prevent clinical recommendation, necessitating improved research standards.

Area of Science:

  • Neurology
  • Biomarker Discovery
  • Diagnostic Accuracy

Background:

  • Ischemic stroke diagnosis presents challenges, particularly in early stages or mild cases where CT scans may be normal.
  • Magnetic resonance imaging (MRI) is not always feasible for all patients.
  • Numerous blood-based biomarkers have been investigated for acute stroke diagnosis.

Purpose of the Study:

  • To systematically review the diagnostic literature on blood biomarkers for acute ischemic stroke.
  • To assess the utility and limitations of single biomarkers and biomarker panels.
  • To provide recommendations for future research in this field.

Main Methods:

  • Conducted a systematic review of diagnostic studies on stroke biomarkers.
  • Included 21 studies evaluating 58 individual biomarkers and 7 biomarker panels.
  • Analyzed study designs, reporting quality, sensitivity, and specificity.

Main Results:

  • All evaluated biomarkers demonstrated either high sensitivity or specificity.
  • Significant limitations were identified in the design and reporting of all included studies.
  • No single biomarker or panel currently meets the criteria for clinical recommendation.

Conclusions:

  • Current diagnostic blood biomarkers for ischemic stroke lack sufficient validation for clinical practice.
  • Recommendations are proposed for enhancing the design and reporting of future diagnostic biomarker studies.
  • Improved research methodology is crucial for establishing reliable blood tests for stroke diagnosis.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...